Non-high-density lipoprotein cholesterol predicts cardiovascular risk better than remnant cholesterol in patients with type 2 diabetes mellitus

QR Code

Non-high-density lipoprotein cholesterol predicts cardiovascular risk better than remnant cholesterol in patients with type 2 diabetes mellitus

BackgroundCardiovascular disease (CVD) is a leading cause of morbidity in patients with type 2 diabetes mellitus (T2DM). Non-high-density lipoprotein cholesterol (non-HDL-c) and remnant cholesterol (RC) have emerged as promising markers of atherogenic risk, but their comparative predictive performan...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paul Nsiah, Samuel Acquah, Ansumana Sandy Bockarie, George Adjei, Ebenezer Aniakwaa-Bonsu, Oksana Ryabinina
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	non-high-density lipoprotein cholesterol remnant cholesterol type 2 diabetes mellitus cardiovascular risk insulin resistance atherogenic dyslipidemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1551203/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Predictive Effects of Atherogenic Indices and Remnant Cholesterol on Gestational Diabetes Mellitus Risk
by: Cheng Y, et al.
Published: (2025-07-01)

Association of Cumulative Exposure to Triglyceride and Remnant Cholesterol With the Risk of Cardiovascular Disease in Hypertensive Patients With Target LDL‐C
by: Shuang Guo, et al.
Published: (2025-06-01)

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study
by: Jiao Liu, et al.
Published: (2025-08-01)

Two‐Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study
by: Dan Wang, et al.
Published: (2025-06-01)

Serum albumin combined with high-density lipoprotein cholesterol as a novel marker to predict coronary heart disease: are their associations multiplicative or rateable?
by: Li He, et al.
Published: (2025-07-01)

Linking Lipid Profile to Stress Urinary Incontinence in US Women: A National Cross-Sectional Study
by: Lu M, et al.
Published: (2025-06-01)

Association between remnant cholesterol levels and reversion to normoglycemia from prediabetes: a 5-year longitudinal cohort study of Chinese non-obese adults
by: Wei Liu, et al.
Published: (2025-07-01)

Association between triglycerides and remnant cholesterol levels and spine bone mineral density in Duchenne muscular dystrophy
by: Yayu Wang, et al.
Published: (2025-06-01)

Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review
by: Subodh Bashyal, et al.
Published: (2025-07-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

Impact of remnant cholesterol on short-term mortality in acute decompensated heart failure: cohort study evidence from Jiangxi, China
by: Guoan Jian, et al.
Published: (2025-08-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

Cholesterol and Bone Resorption: Yet Another Link Between the Bone and Cardiovascular Systems
by: Gordon L. Klein
Published: (2025-04-01)

The relationship between remnant cholesterol and future renal function decline in middle-aged and elderly Chinese populations: the mediating role of uric acid and white blood cells
by: Ying Wei, et al.
Published: (2025-12-01)

Relationship Between Remnant Cholesterol and Risk of Heart Failure in a Community Population Without Cardiovascular Disease: Results of the China Patient‐Centered Evaluative Assessment of Cardiac Events Million Persons Project
by: Qiujin Huang, et al.
Published: (2025-06-01)

Beyond LDL-C: discordant small dense LDL cholesterol stratifies hypertension risk in a Chinese longitudinal cohort
by: Xiaofei Wu, et al.
Published: (2025-06-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

Genetic aspects of decreased low-density lipoprotein cholesterol values
by: A. N. Meshkov, et al.
Published: (2023-12-01)

Associations of changes in lipid metabolism parameters and the severity of COVID-19 infection in Novosibirsk residents
by: A. A. Karaseva, et al.
Published: (2022-09-01)

Dyslipidemia in the Russian Federation: population data, associations with risk factors
by: O. M. Drapkina, et al.
Published: (2023-12-01)

Non-linear association between low-density lipoprotein cholesterol and risk of prediabetes: a retrospective cohort study based on Chinese adults
by: Long He, et al.
Published: (2025-06-01)

Uptake of cholesterol esters being a part of the different fractions of blood plasma lipoproteins by rats organs and tissues
by: L. M. Polyakov, et al.
Published: (2020-01-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

Cholesterol of Low-Density Lipoprotein-Containing Circulating Immune Complexes Improves Prognosis of Asymptomatic Carotid Atherosclerosis
by: A. N. Orekhov, et al.
Published: (2024-06-01)

Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders
by: S. A. Shalnova, et al.
Published: (2022-09-01)

Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now
by: S. A. Shalnova, et al.
Published: (2024-12-01)

METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS
by: N. V. Perova, et al.
Published: (2016-01-01)

Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling
by: Li Jun, et al.
Published: (2025-08-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

PATHOGENESIS AND TREATMENT OF CHOLESTEROL CHOLECYSTOLITHIASIS (REVIEW)
by: YA. L. Turumin, et al.
Published: (2012-04-01)

Targeting to high density lipoprotein cholesterol: new insights for inflammatory bowel disease treatment
by: Xiaotong Wang, et al.
Published: (2025-07-01)

Tissue specific role of ABCA1 in lung cholesterol homeostasis under high-cholesterol diet
by: Jian Ma, et al.
Published: (2025-07-01)

THE EFFECT OF STRATIFIED DOSES OF CURRY LEAF EXTRACT (MURRAYA KOENIGII) ON TOTAL CHOLESTEROL AND TRIGLYCERIDES IN MALE SPRAGUE-DAWLEY RATS INDUCED BY HIGH FAT FEED
by: Muhammad Iqbal Reynaldi, et al.
Published: (2021-01-01)

Multifocal cholesterol granulomas of the anterior mediastinum
by: Takehiko Manabe, et al.
Published: (2020-07-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Cholesterol crystal embolization induced kidney disease
by: Shohan Pervaze, et al.
Published: (2025-08-01)

About atypical dyslipidemia variants in myocardial infarction and unstable angina
by: B. M. Lipovetsky
Published: (2009-10-01)

Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease
by: A. E. Nikitin, et al.
Published: (2020-03-01)

Analysis of Spectral Characteristics of Certain Polyene Antibiotics in the Presence of Dmso and Cholesterol
by: G. H. Sultanova, et al.
Published: (2024-03-01)

The role of increased lipoprotein (a) and apolipoprotein B-100 levels, and their link to cholesterol and triglyceride concentration in coronary heart disease patients
by: G. G. Arabidze, et al.
Published: (2006-10-01)